INDEGENE
Back to Balance Sheet
|
INDEGENE Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹1,966 Cr | ₹1,180 Cr | ₹960 Cr | ₹690 Cr | ₹260 Cr |
What is the latest Net Current Assets ratio of INDEGENE ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹1,966 Cr |
| Mar2024 | ₹1,180 Cr |
| Mar2023 | ₹960 Cr |
| Mar2022 | ₹690 Cr |
| Mar2021 | ₹260 Cr |
How is Net Current Assets of INDEGENE Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,966 Cr | 66.58 | |
| Mar2024 | ₹1,180 Cr | 22.96 | |
| Mar2023 | ₹960 Cr | 39.16 | |
| Mar2022 | ₹690 Cr | 165.36 | |
| Mar2021 | ₹260 Cr | - | |
Compare Net Current Assets of peers of INDEGENE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDEGENE | ₹10,881.8 Cr | 2.6% | -5.7% | -13% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,837.0 Cr | 1% | 3.8% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,175.0 Cr | -1.7% | -4.1% | 3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,394.0 Cr | -0% | -3% | 33.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,999.0 Cr | -1.3% | -1.3% | 8.6% | Stock Analytics | |
| CIPLA | ₹100,379.0 Cr | -1.1% | -6.3% | -18.3% | Stock Analytics | |
INDEGENE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDEGENE | 2.6% |
-5.7% |
-13% |
| SENSEX | -0.8% |
-11.7% |
-3.6% |
You may also like the below Video Courses